Cisatracurium is a neuromuscular blocking agent which binds to cholinergic receptors on the motor end-plate to antagonise the action of acetylcholine.

Cisatracurium is indicated for use during surgical and other procedures and in intensive care in adults and children aged 1 month and over.It can  also  be used as an adjunct to general anaesthesia, or sedation in the Intensive Care Unit (ICU) to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation.

Active ingredient Pharmaceutical form Package Therapeutic target
  • Cisatracurium Besylate
  • Sol. for Injection

  • Sol. for Injection

  • 2mg/ml

  • 5mg/ml

  • Anaesthetic

Other products in "International"